文献速递妇科

前哨淋巴结(SLN)定位在高危子宫内膜癌中的性能

Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2017-09-22

本研究回顾了2010年11月至2016年11月间128例高危子宫内膜癌患者,均行SLN定位后盆腔±腹主动脉旁淋巴结清扫。双侧检出时仅1例假阴性,敏感度95.8%、阴性预测值98.2%。作者认为SLN定位似乎是高危子宫内膜癌合适的分期方法。

要点

  • 双侧SLN检出时仅1例假阴性,敏感度95.8%,阴性预测值98.2%。
  • 41例(32%)盆腔淋巴结阳性;行腹主动脉旁取样62例中11例(17.7%)转移,且均伴盆腔淋巴结阳性。

核心结论

  • 作者认为,鉴于本研究观察到的高敏感度和高阴性预测值,SLN定位似乎是高危子宫内膜癌合适的分期方法。

研究设计与样本

  • 回顾性分析2010年11月至2016年11月间接受初次手术、SLN定位后行盆腔±腹主动脉旁淋巴结清扫的高危子宫内膜癌(3级子宫内膜样、浆液性、癌肉瘤、透明细胞及未分化)患者共128例。

主要发现

  • 128例中41例(32%)盆腔淋巴结阳性;48.8%(62/128)行腹主动脉旁淋巴结取样,其中17.7%(11/62)发现腹主动脉旁转移,且全部伴盆腔淋巴结阳性。
  • SLN阳性30.4%(39/128),包括7例孤立肿瘤细胞(ITC)、4例微转移和28例宏转移。
  • 双侧SLN检出时仅出现1例假阴性,敏感度95.8%,阴性预测值98.2%。

临床怎么用

  • 作者认为SLN定位似乎是高危子宫内膜癌合适的分期方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While the accuracy of the SLN procedure has been validated in patients with low risk EC, its relevance for high-risk EC remains debated. The aim of this study was to evaluate the accuracy of SLN mapping in patients with high-risk EC. STUDY METHOD: We reviewed all patients with high risk EC (grade 3 endometrioid, serous, carcinosarcoma, clear cell and undifferentiated) who underwent primary surgery with SLN mapping followed by pelvic +/- paraaortic lymphadenectomy, between November 2010 and November 2016. RESULTS: Among 128 patients who underwent SLN mapping followed by a pelvic lymph node dissection, 41 (32%) had a positive pelvic lymph node. Overall, 48.8% of patients underwent paraaortic node sampling (62/128). Paraaortic lymph node metastasis was identified in 17.7% of patients in whom a para-aortic lymph node dissection was performed (11/62), and all had positive pelvic lymph nodes as well. Successful SLN mapping occurred in 115/128 (89,8%) patients, with a bilateral detection rate at 63.2% (81/128). Positive SLNs were identified in 30.4% of patients (39/128) including 7 isolated tumor cells (ITC), 4 micrometastasis and 28 macrometastasis. When the SLNs were detected bilaterally, only one false negative case occurred, providing a sensitivity and negative predictive value of 95.8% and 98.2% respectively. CONCLUSION: Accurate surgical staging is an important prognostic predictor of survival in patients with endometrial cancer. Given the high sensitivity and high negative predictive value found in our study, we believe that the use of SLN mapping appears to be an appropriate staging procedure in high-risk endometrial cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Touhami O, Grégoire J, Renaud MC, et al. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer. Gynecol Oncol. 2017. PMID: 28942993. doi:10.1016/j.ygyno.2017.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。